Elan News
Most Popular Elan Story
Biogen CEO: Pharma too wimpy to deal
Biogen Idec CEO to Big Pharma: You just didn't have the guts to make a deal. In an interview with the Boston Globe this week, Biogen honcho Jim Mullen said major drug makers are more conservative Read more...
Latest Headlines
- October 27, 2011
- May 9, 2011
- April 20, 2011
- March 1, 2011
- January 21, 2011
- December 22, 2010
- December 16, 2010
- October 27, 2010
- October 26, 2010
- September 17, 2010
- September 13, 2010
- September 10, 2010
- September 8, 2010
- September 7, 2010
- August 19, 2010
- August 17, 2010
- August 12, 2010
- August 10, 2010
- July 22, 2010
- July 16, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
